Hepatitis C News and Research

Latest Hepatitis C News and Research

Hard lessons from a city that tried to privatize public health

If you were growing up in Detroit in the 1970s or '80s, chances are you knew the city's Herman Kiefer public health complex by both sight and reputation.

6 Aug 2021

Study: Neglecting development of therapeutics may repeat history and replicate vaccine inequality

A new policy report released today by the global non-profit research and development organization Drugs for Neglected Diseases initiative (DNDi) highlights how the development of therapeutics has been relatively neglected in the global response to COVID-19 and warns that with the few treatment innovations available principally in high-income countries, we risk repeating history and replicating the vaccine inequality that has become a defining characteristic of this global pandemic.

6 Aug 2021

Investigational treatment improves survival rate of babies lacking thymus

An investigational treatment pioneered by a Duke Health pediatrician resulted in a one-year survival rate of 77% among children born with a rare condition in which they lack an immune system.

4 Aug 2021

Researchers develop nanofibrous filters that can capture and kill airborne coronaviruses under visible light irradiation

A new study discusses the development of photosensitized electrospun nanofibrous membranes capable of capturing and inactivating SARS-CoV-2 aerosols.

4 Aug 2021

Research: Only 26% of areas in the UK have an effective pathway in place for early liver disease detection

New research published today in a peer review journal shows only 26% of areas in the UK have an effective pathway in place for the early detection of liver disease.

4 Aug 2021

Social and spatial networks influence the risk of HIV or hepatitis C in people who inject drugs

The risk of HIV or hepatitis C in people who inject drugs is influenced as much by their social interactions and the venues where they inject as other risk factors, according to a study published today in eLife.

3 Aug 2021

Existing drug may be effective in treating SARS-CoV-2

Scientists from the University of Chicago have found that the drug masitinib may be effective in treating COVID-19.

2 Aug 2021

Mini-antibodies efficiently block SARS-CoV-2 virus

Göttingen researchers have developed mini-antibodies that efficiently block the coronavirus SARS-CoV-2 and its dangerous new variants.

28 Jul 2021

Existing drug may be effective in treating COVID-19

A new University of Chicago study has found that the drug masitinib may be effective in treating COVID-19.

21 Jul 2021

Yeast expressed, RBD-based vaccine provides robust immune responses against SARS-CoV-2

The ongoing coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused over 190 million cases worldwide. Of these, over 4 million have died due to the infection.

20 Jul 2021

Plant-based vaccines for COVID-19 and other viruses

A review published in the journal Vaccines, explored the history and current status of plant-produced vaccine candidates against enveloped viruses, focusing on virus-like particles (VLPs), which mimic authentic viral structures without containing infectious genetic material.

19 Jul 2021

India's Mission Indradhanush improves vaccination outcomes for children

Researchers at CDDEP recently published 'Improving vaccination coverage and timeliness through periodic intensification of routine immunization: evidence from Mission Indradhanush' where they evaluated the performance of India's Mission Indradhanush (MI) child vaccination campaign -- a periodic intensification of the routine immunization program.

16 Jul 2021

COVID-19 vaccine candidate that can be produced in yeast proves effective in macaques

Researchers in the United States have designed a modular protein subunit vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that elicited a strong immune response in macaques and prevented the animals from developing coronavirus disease 2019 (COVID-19).

15 Jul 2021

Yale School of Public Health and Tevogen Bio partner to expand school's regulatory sciences program

The Yale School of Public Health is partnering with Tevogen Bio, a clinical stage biotechnology company, on a major expansion of the school's regulatory sciences program.

14 Jul 2021

Natural compound 'pheophorbide a' demonstrates robust antiviral activity against SARS-CoV-2 in vitro

A team of scientists from France has recently demonstrated photosensitive antiviral activity of the natural compound pheophorbide a (Pba) against a broad range of enveloped viruses, including coronaviruses.

12 Jul 2021

Selective immunotoxins may help treat liver fibrosis

Chronic alcohol abuse and hepatitis can injure the liver and lead to fibrosis, the buildup of collagen and scar tissue. As a potential approach to treating liver fibrosis, University of California San Diego School of Medicine researchers and their collaborators are looking for ways to stop liver cells from producing collagen.

12 Jul 2021

HIV research center set up in the UK to address health inequalities and develop new treatments

A trailblazing HIV research center is being set up in the UK to address health inequalities and improve quality of life for everyone affected by HIV.

12 Jul 2021

WHO and HRP launch new guideline for screening and treatment of cervical cancer

Too many women worldwide – particularly the poorest women – continue to die from cervical cancer; a disease which is both preventable and treatable.

8 Jul 2021

Plant compounds inhibit Mpro of SARS-CoV-2 and HCoV-229E in vitro

A group of researchers recently discussed their findings that a group of plant flavonols and dihydroflavonols exhibit antiviral efficacy against both SARS-CoV-2 and HCoV-229E.

6 Jul 2021

Grapevine leaf extract inhibits SARS-CoV-2 and HSV-1 replication in the lab

Researchers in Italy have shown that leaf extract from the common grapevine – Vitis vinifera – exhibits significant antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

1 Jul 2021

Hepatitis C News and Research

Latest Hepatitis C News and Research

Hard lessons from a city that tried to privatize public health

Study: Neglecting development of therapeutics may repeat history and replicate vaccine inequality

Investigational treatment improves survival rate of babies lacking thymus

Researchers develop nanofibrous filters that can capture and kill airborne coronaviruses under visible light irradiation

Research: Only 26% of areas in the UK have an effective pathway in place for early liver disease detection

Social and spatial networks influence the risk of HIV or hepatitis C in people who inject drugs

Existing drug may be effective in treating SARS-CoV-2

Mini-antibodies efficiently block SARS-CoV-2 virus

Existing drug may be effective in treating COVID-19

Yeast expressed, RBD-based vaccine provides robust immune responses against SARS-CoV-2

Plant-based vaccines for COVID-19 and other viruses

India's Mission Indradhanush improves vaccination outcomes for children

COVID-19 vaccine candidate that can be produced in yeast proves effective in macaques

Yale School of Public Health and Tevogen Bio partner to expand school's regulatory sciences program

Natural compound 'pheophorbide a' demonstrates robust antiviral activity against SARS-CoV-2 in vitro

Selective immunotoxins may help treat liver fibrosis

HIV research center set up in the UK to address health inequalities and develop new treatments

WHO and HRP launch new guideline for screening and treatment of cervical cancer

Plant compounds inhibit Mpro of SARS-CoV-2 and HCoV-229E in vitro

Grapevine leaf extract inhibits SARS-CoV-2 and HSV-1 replication in the lab

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Hepatitis C News and Research

Latest Hepatitis C News and Research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in